Welcome
Support Centre
10 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes


International Standard Randomised Controlled Trial Number Register
Showing records: 5931 to 5940 of 10349
SEARCH FOR RESULTS ORDER DIRECTION MAX RESULTS
5931 Balloon angioplasty versus stenting with nitinol stents in the superficial femoral artery
ISRCTN: ISRCTN52947529
Sponsor: Medical University Vienna (Austria)
Date assigned: 26 May 2006
5932 Efficacy of add-on mirtazapine on clinical and neuropsychologic parameters in schizophrenic patients treated with conventional antipsychotics: a double-blind, placebo-controlled trial with an open-label extension phase
ISRCTN: ISRCTN00721331
Sponsor: Stanley Medical Research Institute (USA)
Date assigned: 25 May 2006
5933 Orlistat therapy in clozapine- and olanzapine-treated patients who are overweight or obese
ISRCTN: ISRCTN65731856
Sponsor: The Stanley Medical Research Institute (SMRI) (USA)
Date assigned: 25 May 2006
5934 Effect of a multidisciplinary in-patient rehabilitation program for patients with ankylosing spondylitis: a randomised controlled trial
ISRCTN: ISRCTN75685576
Sponsor: The Norwegian Government (Helse Øst)
Date assigned: 25 May 2006
5935 Randomised controlled trial of a specialist behaviour therapy team versus treatment as usual
ISRCTN: ISRCTN62134865
Sponsor: South Essex Partnership NHS Trust (UK)
Date assigned: 25 May 2006
5936 Bladder Cancer Prognosis Programme (incorporating SELENIB trial)
ISRCTN: ISRCTN13889738
Sponsor: University of Birmingham (United Kingdom)
Date assigned: 24 May 2006
5937 A phase I, single-dose, double-blind, randomised, dose escalation study to assess the safety, tolerability and pharmacokinetics of NNZ-2566 when administered as a 10-minute infusion
ISRCTN: ISRCTN67656669
Sponsor: Neuren Pharmaceuticals (New Zealand)
Date assigned: 24 May 2006
5938 Levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitaemia
ISRCTN: ISRCTN27232551
Sponsor: University of Oxford (United Kingdom)
Date assigned: 24 May 2006
5939 Ultrasound Cannulation of the Internal Jugular Vein
ISRCTN: ISRCTN61258470
Sponsor: General State Hospital of Athens (Greece)
Date assigned: 23 May 2006
5940 Randomised, controlled, multicenter, pilot study comparing qigong and back school for elderly patients with chronic neck pain
ISRCTN: ISRCTN77101807
Sponsor: Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)
Date assigned: 23 May 2006
RESULT PAGE
|< < 590 591 592 593 594 595 596 597 598 > >|
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central